Learn More
Apexbio Technology LLC LDN-193189 1062368-24-4 5mg

Supplier: Apexbio Technology LLC A83245
LDN-193189 (CAS 1062368-24-4) is a selective small molecule inhibitor targeting type I bone morphogenetic protein (BMP) receptors specifically activin receptor-like kinase-2 (ALK2) and ALK3 It inhibits ALK2 and ALK3 with IC50 values of approximately 5 nM and 30 nM respectively In vitro studies using C2C12 cells demonstrated that LDN-193189 suppresses BMP-induced phosphorylation of Smad1/5/8 as well as p38 MAPK and Akt signaling Additionally research using bronchial epithelial (Beas2B) cells and murine models indicates that LDN-193189 prevents BMP2-induced E-cadherin downregulation and maintains epithelial barrier integrity LDN-193189 is thus valuable for studying BMP-mediated signaling pathways and related physiological processes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.